de Tejada; Inigo Saenz

Patent Applications and Registrations

Patent applications and USPTO patent grants for de Tejada; Inigo Saenz.The latest application filed is for "phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use".

Company Profile

0.16.6

de Tejada; Inigo Saenz - Madrid ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nitrosated and nitrosylated prostaglandins, compositions and methods of use Grant 7,772,278 - Garvey , et al. August 10, 2	2010-08-10
Nitrosated and nitrosylated prostaglandins, compositions and methods of use Grant 7,449,595 - Garvey , et al. November 11, 2	2008-11-11
Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use App 20080009498 - Garvey; David S. ; et al.	2008-01-10
Nitrosated and nitrosylated prostaglandins, compositions and methods of use App 20070112067 - Garvey; David S. ; et al.	2007-05-17
Nitrostated and nitrosylated prostaglandins, compositions and methods of use Grant 7,176,238 - Garvey , et al. February 13, 2	2007-02-13
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds App 20050187222 - Garvey, David S. ; et al.	2005-08-25
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use Grant 6,930,113 - Garvey , et al. August 16, 2	2005-08-16
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses App 20050065161 - Garvey, David S. ; et al.	2005-03-24
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses App 20030158184 - Garvey, David S. ; et al.	2003-08-21
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use App 20030023087 - Garvey, David S. ; et al.	2003-01-30
Endogenous nitric oxide synthesis under conditions of low oxygen tension Grant 6,436,997 - de Tejada August 20, 2	2002-08-20
Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses Grant 6,417,162 - Garvey , et al. July 9, 2	2002-07-09
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use Grant 6,417,207 - Garvey , et al. July 9, 2	2002-07-09
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use Grant 6,331,543 - Garvey , et al. December 18, 2	2001-12-18
Compositions and methods for treating sexual dysfunctions Grant 6,323,211 - Garvey , et al. November 27, 2	2001-11-27
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Grant 6,316,457 - Garvey , et al. November 13, 2	2001-11-13
Treatment of sexual dysfunction with N-hydroxyguanidine compounds Grant 6,277,884 - de Tejada August 21, 2	2001-08-21
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Grant 6,197,778 - Garvey , et al. March 6, 2	2001-03-06
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Grant 6,177,428 - Garvey , et al. January 23, 2	2001-01-23
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Grant 6,172,068 - Garvey , et al. January 9, 2	2001-01-09
Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses Grant 6,172,060 - Garvey , et al. January 9, 2	2001-01-09
Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses Grant 5,994,294 - Garvey , et al. November 30, 1	1999-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.